Edition:
India

Morphosys: I-Mab Gets IND Clearance For Trials Of TJ202/MOR202


Monday, 14 Oct 2019 

Oct 14 (Reuters) - MORPHOSYS AG ::I-MAB BIOPHARMA AND MORPHOSYS ANNOUNCE IND CLEARANCE TO INITIATE CLINICAL TRIALS OF TJ202/MOR202 FOR THE TREATMENT OF MULTIPLE MYELOMA IN MAINLAND CHINA.I-MAB WILL NOW BE EXPANDING CLINICAL TRIALS WITH TJ202/MOR202 INTO MAINLAND CHINA.